
Consumers Union finds fault with Part D ratings
Consumers Union, publisher of Consumer Reports, criticizes the Centers for Medicare & Medicaid Service's system for rating Medicare Part D prescription drug plans as meaningless.
The current system for rating and comparing Medicare Part D prescription drug plans (PDPs) is confusing, meaningless, and should be reformed according to Consumers Union, publisher of Consumer Reports. In a letter sent to Kerry Weems, CMS' acting administrator, the consumer organization faulted the rating system for ignoring information such as how much PDPs increased drug prices during the year, or whether a PDP has more lower-cost generics on its drug list than high-priced brands. Instead, the rating system includes information of little use to consumers, like the ease for pharmacist in filling a prescription. CMS recently released information on the
To see more Hot off the Press news articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

















































































































































